Meet Gastric and Adrenal Surgeon Vivian Strong
Vivian E. Strong, MD, FACS
Iris Cantor Chair
Minimally Invasive Expertise; Stomach Cancer; Tumors of the Adrenal Gland, Splenectomy, Small Intestine, Distal Pancreas; Hernias
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Strong accepts the following list of insurance providers. Select your insurance provider to see more details.
Memorial Sloan Kettering is an in-network provider with Aetna HMO, POS, and PPO plans. Aetna does not include us in any of the plans you can purchase through the insurance exchanges or through Medicare. Please ask your insurance if you need a one-time referral. MSK has an agreement with the Aetna Transplant Program for all Aetna's commercial products.
Memorial Sloan Kettering is a designated Blue Distinction Center for bone marrow transplant and CAR-T.
We understand that there may be many complexities involved with insurance coverage purchased through the health exchange network of the Affordable Care Act. We’re here to help. If you have questions about how your care will be covered by an insurance provider, or need help navigating a change in coverage, please call us at 646-227-3378; if you are not a resident of New York, you can call us at 866-248-1274. Our team is here to listen to your concerns and assist you in any way we can. We want our care to be as accessible and affordable for as many people as possible.
Memorial Sloan Kettering is an in-network provider with CIGNA's HMO, POS, and PPO plans. CIGNA does not include us in any of the plans you can buy through the insurance exchanges.
- If you are a New York State resident: Please ask your insurance if you need a one-time referral.
- If you live outside of New York State: Please ask your insurance if you have in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with EmblemHealth’s PPO, EPO, POS, HMO plans. EmblemHealth includes GHI, HIP, Vytra, and ConnecticCare (in NYS Only). You must bring a referral from your Emblem primary care doctor to your first appointment. In-network participation exceptions include:
- Emblem’s HIP Commercial Millennium, Select Care and Enhanced Care Prime networks is not in-network with Memorial Sloan Kettering.
- Please call Emblem to confirm if your specific plan is in-network.
For information regarding Memorial Sloan Kettering’s participation with Emblem’s Medicare Advantage Plans, please refer to the Medicare & Medicaid page
Memorial Sloan Kettering is an in-network provider with Empire Blue Cross Blue Shield (Wellpoint) of New York Indemnity, HMO, EPO, PPO, POS and Medicare Advantage plans, with the following exceptions:
- Empire Blue Cross Blue Shield does not include us in any of the plans you can buy through the insurance exchanges.
- Please call Empire BCBS to confirm if your specific plan is in-network with Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with HealthFirst’s commercial products; these commercial products are not purchased on the insurance exchanges.
Memorial Sloan Kettering is an in-network provider with HealthSmart’s Accel, HSPC, and HPO networks.
For our NJ locations, Memorial Sloan Kettering is an in-network provider with most Horizon Blue Cross Blue Shield of New Jersey plans for individuals, families, and small businesses. Horizon members with Blue Card Access (there would be a suitcase logo on the front of the card) may have access to our NY locations. Please call Horizon to confirm if your plan is in-network in NY.
Memorial Sloan Kettering is a designated Center of Excellence by Humana.
Memorial Sloan Kettering is a designated Center of Excellence by Interlink Health Services.
Memorial Sloan Kettering is a designated Center of Excellence by Lifetrac.
Memorial Sloan Kettering is an in-network provider for all MagnaCare health plans except those products you can buy through the insurance exchanges.
For information about Medicare and Medicaid, please visit this page
Memorial Sloan Kettering is an in-network provider with some Multiplan/Beech Street/PHCS plans. Contact your insurance carrier to find out if your plan provides in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is a designated Center of Excellence by Multiplan.
If you are covered by more than one insurance plan, you will want to determine your benefits from both plans. First, you need to determine which one is your primary insurance provider by contacting your employee benefits office or your insurance carriers. After you find out which is your primary insurance provider, you should then contact your insurance carrier to determine if you have access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with some MVP plans. Contact your insurance carrier to find out if your plan provides in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider for New York State employees who have enrolled in UnitedHealthcare's Cancer Resource Services. If you have the Empire Plan, you should call Cancer Resources Services at 866-936-6002 to verify and enroll in this coverage.
Memorial Sloan Kettering is in-network with Oscar’s Circle Plus Network, a part of its Small Group Broad line that is offered only to select small business groups. Oscar does not include Memorial Sloan Kettering as an in-network provider for any of its individual plans. Please confirm eligibility with your insurance carrier.
Most Blue Cross Blue Shield plans include Memorial Sloan Kettering as an in-network provider. Contact your insurance company to confirm if Memorial Sloan Kettering is in-network.
We have agreements with several insurance companies that may provide additional coverage for cancer patients. These benefit programs include:
- AXA Assistance USA
- Beech Street
- Integrated Health Plans
- National Health Administrators
- National Preferred Provider Network
- UnitedHealthcare's Cancer Resource Services
- United Resource Network
- Veterans Choice Program
Memorial Sloan Kettering is an in-network provider with Oxford’s Freedom and Liberty plans as well as the Metro Plan (which is only offered to small business groups and no longer offered as individual plans). Please confirm with your insurance if you need a one-time referral. Note: Oxford’s Medicare Managed Care plan — Secure Horizon — does not include Memorial Sloan Kettering as an in-network provider. Oxford does not include us in any of the plans you can buy through the insurance exchanges.
Memorial Sloan Kettering is an in-network provider with the World Trade Center Health Program.
Memorial Sloan Kettering is an in-network provider with QualCare's PPO and HMO/POS network.
Memorial Sloan Kettering is a designated Center of Excellence by Specialty Care Management.
Hospital and physician services may be covered by TRICARE. Please call your TRICARE plan to confirm coverage at Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with UnitedHealthCare's HMO, POS, and PPO plans. Please confirm with your insurance if a one-time referral is needed.
UnitedHealthCare's Medicare Managed Care plan does not include Memorial Sloan Kettering as an in-network provider.
United does not include us in any of the plans you can buy through the insurance exchanges.
Memorial Sloan Kettering is a designated Center of Excellence by UnitedHealthcare.
Contact and Location
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
MD, Weill Cornell Medical College
General Surgery - New York Presbyterian/Cornell Medical Center
Advanced Laparoscopic Surgery - New York Presbyterian/Weill Cornell Medical Center
I am a board-certified surgeon with advanced training in minimally invasive techniques (laparoscopy and robotic surgery). I am dedicated to applying my technical expertise and clinical interests primarily to patients with stomach (gastric) cancer and adrenal tumors.
I am a member of Memorial Sloan Kettering’s Gastric Disease Management Team — a multidisciplinary team of surgeons, medical oncologists, pathologists, and other medical professionals who specialize in the diagnosis and treatment of gastric cancer. The combined expertise of our specialized team allows us to come up with the best plan for each patient.
In treating someone with stomach cancer, my goal is both to cure the patient of cancer and preserve his or her quality of life, both in the short and long term. I take all clinical data into account and select a surgical approach that has the greatest chance of accomplishing both goals.
In 2005, I introduced laparoscopic surgery as an option for patients with gastric cancer, and in 2009 I published the results of this approach in the Annals of Surgical Oncology. My research showed that the minimally invasive approach produces success rates comparable to those of traditional open surgery, with fewer complications, less blood loss and post-operative pain, and a shorter hospital stay. Laparoscopic surgery is an excellent approach for some, but not all, patients with the disease. I also developed a program in robotic gastrectomy in 2009, and apply this technique for selected patients. Results are promising and show decreased pain and quicker recovery for patients.
My research focuses not only on minimally invasive approaches and new technologies to better treat patients with gastric cancer, but also on molecular and genetic factors that may explain why some stomach cancers behave differently than others. I am particularly interested in differences in gastric cancer in the United States compared to Asian countries, and I am collaborating on an international level with gastric cancer surgeons in other countries to study this question. At Memorial Sloan Kettering, I am also working with pathologists and basic science researchers to study basic genetic factors that explain differences in certain types of gastric cancer, including questions relating to other gastric tumors, such as gastric gastrointestinal stromal tumors (GIST) and gastric carcinoids.
On a national and international level, I am a member of the National Comprehensive Cancer Network (NCCN) Esophageal and Gastric Advisory Group, which establishes the national guidelines for hospitals across the country regarding recommended standards to diagnose and treat gastric cancer. I have lectured at gastric cancer specialty meetings in Asia and Europe, including the International Gastric Cancer Congress (IGCC) Meeting in 2009, on novel research and minimally invasive surgery for this disease.
I also treat patients with adrenal tumors, and since 2005, I have overseen the adrenal database at Memorial Sloan Kettering, forming connections with endocrinologists, pathologists, and medical oncologists who share an interest in adrenal disorders. I have lectured internationally and published about laparoscopic adrenalectomy, which is the minimally invasive removal of tumors of the adrenal gland. I also treat patients with tumors that have metastasized from other primary sites to the adrenal gland, and have studied and published the collective experience of surgeons at Memorial Sloan Kettering to help better understand who is most suited for surgical removal of these tumors. I have also performed studies to define how patients with pheochromocytoma (a hormone-producing tumor of the adrenal gland) should be followed and how to determine if such tumors may recur.
Minimally invasive techniques may be appropriate for patients with cancerous and pre-cancerous disorders of the distal pancreas, spleen, and small intestine, and I have expertise in laparoscopic surgery for these problems as well.
I typically see new patients on Tuesdays at our 53rd Street location and operate on Mondays and Thursdays. I spend the remainder of my time conducting research, teaching, and lecturing. My contact information is listed below.
Working at a place like Memorial Sloan Kettering is a privilege and it is clear that the patients expect the very best from their physicians. It is gratifying to know you have helped a cancer patient through a part of their treatment and that you may have helped cure them. The hope is to allow people to return to normal life as soon as possible.
Awards and Honors
- Castle Connolly: New York Magazine Top Doctors (2016-2020)
- Clinical Trials Co-Investigated by Dr. Strong
- A Phase II Study of Pembrolizumab Immunotherapy plus Trastuzumab or Trastuzumab Alone after Surgery in Patients with Esophagogastric Tumors
- A Phase III Study of Durvalumab Immunotherapy and FLOT Chemotherapy Before and After Surgery in Patients with Operable Stomach and Gastroesophageal Junction Cancers
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Research and Publications
“Lymphadenectomy for gastric cancer.” Strong VE. In: Master Techniques in Surgery: Gastric Surgery. Nussbaum MS, ed. Philadelphia: Lippincott Williams & Wilkins; 2012.
Visit PubMed for a full listing of Dr. Strong’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Vivian E. Strong discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.